Methyl 5-oxobicyclo[2.2.2]octane-2-carboxylate

Catalog No. :
ACQMXA296
CAS No. :
78478-61-2
Molecular Formula :
C10H14O3
Molecular Weight :
182.22

IUPAC Name:methyl 5-oxobicyclo[2.2.2]octane-2-carboxylate

Methyl 5-oxobicyclo[2.2.2]octane-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg92%$302.00Login to see priceIn stockInquiry
250mg92%$482.00Login to see priceIn stockInquiry
500mg92%$803.00Login to see priceIn stockInquiry
1g92%$1203.00Login to see priceIn stockInquiry
5g92%$3608.00Login to see priceIn stockInquiry
10g92%$6013.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 5-oxobicyclo[2.2.2]octane-2-carboxylate
IUPAC Namemethyl 5-oxobicyclo[2.2.2]octane-2-carboxylate
MDL No.MFCD29059279
Molecular FormulaC10H14O3
Molecular Weight182.22
SMILESO=C(C(CC1CC2)C2CC1=O)OC
InChI KeyDOPKSKFPVYAYCF-UHFFFAOYSA-N
SynonymMethyl 5-oxobicyclo[2.2.2]octane-2-carboxylate | 78478-61-2 | MFCD29059279 | Bicyclo[2.2.2]octane-2-carboxylic acid, 5-oxo-, methyl ester | 146611-35-0 | SCHEMBL3167547 | PB47935 | BS-43012 | SY234010 | CS-0048961 | F30889 | Methyl5-oxobicyclo[2.2.2]octan
CAS No.78478-61-2
PubChem CID12273592

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACQMXA296 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQMXA296 route product structure diagram
    ACQMXA29678478-61-2 In Stock
Inquiry

2. ACQMXA296 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQMXA296 route product structure diagram
    ACQMXA29678478-61-2 In Stock
Inquiry

Comments (0)